InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: Doktornolittle post# 95626

Saturday, 01/14/2017 12:04:43 PM

Saturday, January 14, 2017 12:04:43 PM

Post# of 705232
But one could argue that it is a different indication, being recurrent GBM rather than new GBM. That is the question... would that be enough of a difference in indications for the FDA to ignore a futility finding for the first?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News